Spectral AI, Inc. Class A Common Stock (MDAI) Stock Price

MDAIStock
$1.51−38.62%52W
Market Cap$48.60M
P/E—
PEG Ratio—
Div yield—
Beta1.26

MDAI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-34.03%
Price vs S&P 500 (4W)-7.71%
VGM Score27.41

MDAI Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026-$0.14-$0.13+3.70%(+$0.01)
Q4 2025-$0.14$0.02+114.29%(+$0.16)
Q3 2025-$0.09-$0.13-52.94%(-$0.05)
Q2 2025-$0.08-$0.31-287.50%(-$0.23)

MDAI Analyst Recommendations

Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.25
4.25
4.14
4.14

Industry Peers — Surgical & Medical Instruments(142)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
MDAISpectral AI, Inc. Class A Common Stock
DFC3.2x—42.9%-77.2%$1.51
SYKStryker CorporationCBC4.4x11.8%65.3%21.3%$294.66
MMM3M CompanyCDB3.4x-5.0%39.4%18.4%$164.75
BSXBoston Scientific Corp.CBC3.1x15.2%69.5%19.8%$44.39
BDXBecton, Dickinson and Co.BDA2.5x6.3%46.7%9.6%$191.75
MDLNMedline Inc. Class A common stockCDC1.6x—26.2%6.0%$35.96
RMDResMed Inc.CCB5.9x12.1%61.1%33.4%$238.97
DXCMDexCom, Inc.CBB6.5x19.3%64.3%22.9%$86.04
WSTWest Pharmaceutical Services, Inc.DCA8.5x7.4%36.8%20.4%$384.02
SOLVSolventum CorporationCCB1.8x—54.8%23.9%$85.81
BAXBaxter International Inc.BDB1.1x-0.8%30.7%-2.3%$25.28

About Spectral AI, Inc. Class A Common Stock

Spectral AI develops DeepView, an AI-powered diagnostic system that uses proprietary algorithms and multispectral imaging to assess tissue damage and wound healing. The system has received FDA Breakthrough Device Designation and delivers healing assessments in seconds, enabling physicians to make faster, more accurate treatment decisions. By detecting damage invisible to the naked eye, DeepView aims to improve wound treatment outcomes and streamline clinical workflows.